Clinical Trials Insight: 700040345

Trial Profile

Clinical Trials Insight: 700040345

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Jan 2009

At a glance

  • Drugs VX 500 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Sponsors Vertex Pharmaceuticals
  • Most Recent Events

    • 07 Jan 2009 New trial record.
    • 27 Oct 2008 Status changed from planning to recruiting, according to a Vertex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top